NEUP - Neuphoria Therapeutics Inc
Neuphoria Therapeutics Inc Logo

NEUP - Neuphoria Therapeutics Inc

https://www.neuphoriatx.com
Momentum: Bearish
Recent News
Powered by Alpha Vantage

No recent news found.

AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

None

52W High
$13.34
52W Low
$2.12

MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
N/A
Valuation
Attractive
As of 2024-09-30 (Overview)
Trailing P/E (<15 better)
0.45
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-0.06
EV/Revenue (<3 favorable)
26194.63
P/S (TTM) (<3 favorable)
145.56
P/B (<3 favorable)
1263.00
Ownership
Retail‑heavy
Source: Overview
Insiders (1–5% typical)
0.00%
Institutions (25–75% balanced)
9.36%
Shares Outstanding
1,627,300
Float
0
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
As of 2024-09-30 (Overview)
Revenue (TTM)
662,720
Gross Profit (TTM)
662,720
EPS (TTM)
10.93
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
-5.13%
ROE (TTM) (>15% strong)
N/A
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
N/A
Momentum
Bearish momentum
Value
1.9008
Previous
2.0066
Trend
Falling
Signal Cross
No cross

As of
Sep. 12, 2025